CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-23 | HENNEMAN JOHN B III Director | Grant or award | +500 | 1,279 | ||
| 2023-08-23 | HENNEMAN JOHN B III Director | Grant or award · Stock Options (Right to Buy) | +2,000 | 2,000 | ||
| 2023-08-23 | Peters Richard Director | Grant or award | +500 | 1,029 | ||
| 2023-08-23 | Peters Richard Director | Grant or award · Stock Options (Right to Buy) | +2,000 | 2,000 | ||
| 2023-08-23 | Duey Marc Director | Grant or award | +500 | 208,878 | ||
| 2023-08-23 | Duey Marc Director | Grant or award · Stock Options (Right to Buy) | +2,000 | 2,000 | ||
| 2023-08-23 | Seizinger Bernd R. Director | Grant or award | +500 | 26,825 | ||
| 2023-08-23 | Seizinger Bernd R. Director | Grant or award · Stock Options (Right to Buy) | +2,000 | 2,000 | ||
| 2023-08-23 | BIZZARI JEAN-PIERRE Director | Grant or award · Stock Options (Right to Buy) | +12,500 | 12,500 | ||
| 2023-06-07 | Seizinger Bernd R. Director | Purchase | +6,029 | $3.68 | $22K | 26,325 |
| 2023-06-06 | Seizinger Bernd R. Director | Purchase | +4,068 | $3.63 | $15K | 20,296 |
| 2023-05-05 | Gruia Gabriela Director | Grant or award · Stock Options (Right to Buy) | +12,500 | 12,500 | ||
| 2023-03-09 | Gilad Oren President, CEO | Grant or award | +4,000 | 322,770 | ||
| 2023-03-09 | Gilad Oren President, CEO | Grant or award · Stock Options (Right to Buy) | +16,000 | 16,000 | ||
| 2023-02-27 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award | +1,000 | $5.25 | $5K | 14,493 |
| 2023-01-30 | Hamill John P. SrVP/CFO/Prin. Fin&Acctg. Off | Grant or award | +269,879 | 269,879 | ||
| 2023-01-30 | Hamill John P. SrVP/CFO/Prin. Fin&Acctg. Off | Grant or award · Employee Stock Option (Right to Buy) | +539,758 | 539,758 | ||
| 2022-08-23 | Pamukcu Rifat Director | Conversion | +49,280 | 57,142 | ||
| 2022-08-23 | Pamukcu Rifat Director | Conversion | +271,870 | 14,108 | ||
| 2022-08-23 | Pamukcu Rifat Director | Conversion · Series A Non-Voting Convertible Preferred Stock | −4,928 | 0 |
Page 6 of 10 · 197 trades